Therapeutic Opportunities Presented by Modulation of Cellular Senescence

Area of Science:

• Gerontology and cellular biology
• Investigating the fundamental mechanisms of aging and cellular fate.
• Exploring the role of cellular senescence in aging and disease pathology.

Background:

• Cellular senescence is a permanent growth arrest state with significant phenotypic changes, triggered by various stimuli.
• Senescence plays a role in tumor suppression and other physiological processes, with accumulating evidence linking it to age-related diseases.
• Human premature aging diseases and senescent cell ablation in mice support the model that senescent cell accumulation drives chronic diseases later in life.

Approach:

• Utilizing modern bioinformatic text-mining approaches to identify co-mentions of cell senescence and age-related diseases.
• Reviewing evidence for senescence involvement in highly ranked pathologies based on co-mention analysis.
• Examining potential therapeutic strategies, including polyphenolics and p38 MAP kinase inhibitors, for senescent cell ablation or reversion.

Key Points:

• Senescent cell accumulation is implicated in later-life chronic diseases and impairments.
• Bioinformatic analysis helps rank age-related diseases associated with cellular senescence.
• Therapeutic strategies focus on removing senescent cells or reverting them to a benign state.

Conclusions:

• Targeting cellular senescence is a key emerging goal in translational medicine.
• Senescence may present challenges in the development of bioartificial organs for treating age-related conditions.
• Further research into senescence mechanisms and therapeutic interventions is crucial for combating age-related decline.